CytoDyn CYDY Cash Flow Statement (2010-2026)

OTC CYDY
$0.20 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT
Reported Financials

CytoDyn Quarterly Cash Flow Statement

Periods 64 quarters
Latest May 2026

CytoDyn reported cash from operations of -$4.93M and free cash flow of -$4.93M for the quarter ended May 2026, up 12.9% year over year. This cash flow statement covers 64 quarters of results from Aug 2010 through May 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Aug2010 Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026 May2026
Operating Activities
Net Income
-45.34M-40.08M-41.29M-84.12M-20.99M-26.50M-13.70M-18.64M-11.57M-9.56M-11.92M-16.79M19.23M-4.77M-4.76M-5.96M-5.54M-22.61M-4.69M-9.86M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.95M0.79M0.64M0.58M0.58M0.58M0.57M0.41M0.40M0.14M0.41M0.13M0.13M0.11M0.11M0.06M0.33M
Depreciation & Amortization (CF)Dep. & Amort.
0.28M0.25M0.13M0.12M0.10M0.05M0.01M0.01M0.01M0.01M0.01M0.00M0.01M0.00M0.01M0.00M0.00M0.01M0.00M0.00M
Share-based CompensationStock Comp.
2.60M2.06M-0.44M2.02M1.34M1.78M0.44M0.72M0.50M0.57M0.87M0.47M0.14M0.54M0.34M0.60M0.18M0.18M0.45M0.82M
Deferred Taxes
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
-8.60M-0.16M0.01M0.00M-0.02M-0.96M0.74M-0.85M
Asset Writedowns and ImpairmentWritedown
1.76M1.59M5.56M64.58M2.70M17.93M
Other non-cash itemsOther Non-Cash
18.53M6.79M12.07M0.64M2.02M2.66M4.09M3.04M4.90M8.02M1.18M-0.08M-0.33M
Change in Working Capital
Change in ReceivablesChange Receivables
0.04M0.18M
Change in InventoryChange Inventory
-0.79M-0.78M-0.33M-0.17M
Change in Accured ExpensesChange Accured Exp.
-10.45M-6.74M5.84M8.64M-1.82M-0.21M-1.53M0.46M3.32M1.06M1.97M4.42M-14.30M1.05M0.93M0.99M0.92M17.58M-4.01M3.39M
Change in Other Operating AssetsOther Assets Change
2.37M-1.72M2.61M0.86M1.60M-1.30M-0.93M-1.28M1.61M-1.32M-0.26M-0.92M1.78M0.45M1.25M1.36M-1.99M-0.19M-1.11M-0.72M
Other Working Capital ChangesOther WC Changes
-2.37M1.72M-2.61M-0.86M-1.60M1.30M0.93M1.28M-1.61M1.32M0.26M0.92M-1.78M-0.45M-1.25M-1.36M1.99M0.19M1.11M0.72M
Cash from OperationsCash from Ops.
-31.74M-28.89M-11.05M-6.04M-11.07M-4.41M-6.22M-3.41M-4.50M-2.50M-2.34M-1.65M5.44M-3.59M-4.96M-5.66M-2.45M-4.35M-5.52M-4.93M
Investing Activities
Capital ExpendituresCapex
0.01M0.01M0.02M
Change in Property, Plant and EquipmentChange in PP&E
-0.01M-0.01M-0.02M
Change in IntangiblesChange Intangibless
Cash from Investing ActivitiesCash from Investing
-0.01M-0.01M-0.02M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
0.71M0.14M
Non-Current Debt
-0.71M-0.14M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.71M-0.14M
Change in Capital Stock
Common Stock IssuedStock Issued
3.56M26.62M4.55M7.88M11.52M13.35M1.36M2.88M0.44M2.68M3.44M1.17M0.02M17.09M1.13M
Net Shares Issued and RepurchasedNet Shares Issued
3.56M26.62M4.55M7.88M11.52M13.35M1.36M2.88M0.44M2.68M3.44M1.17M0.02M17.09M1.13M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
3.56M26.62M4.55M7.88M11.52M13.35M1.36M2.88M0.44M2.68M3.44M1.17M0.02M17.09M1.13M
Dividend Payments
Dividends Paid - PreferredDiv. Paid (Pref.)
Dividends Paid - Common and PrefferdDiv Paid (Total)
Other financing activitiesOther financing
0.78M4.62M0.68M-0.01M10.38M
Cash from Financing ActivitiesCash from Financing
4.35M31.23M4.55M7.88M11.52M2.33M14.73M1.35M4.02M0.65M3.63M3.44M9.67M0.02M1.17M-0.12M16.19M1.13M
Additional items
Change in Cash
-27.40M2.33M-6.51M1.87M0.45M-2.07M8.51M-2.06M-0.48M-1.85M1.30M1.79M15.11M-3.59M-4.94M-4.50M-2.57M-4.35M10.67M-3.80M
Ending Cash Balance
6.54M8.88M2.36M4.23M4.68M2.60M11.11M9.05M8.57M6.72M8.02M9.81M24.92M21.34M16.40M11.90M9.33M4.98M15.66M11.85M
Free Cash FlowFCF
-31.75M-28.90M-11.06M-6.04M-11.07M-4.41M-6.22M-3.41M-4.50M-2.50M-2.34M-1.65M5.44M-3.59M-4.96M-5.66M-2.45M-4.35M-5.52M-4.93M
Net Cash FlowNCF
-27.40M2.33M-6.51M1.84M0.45M-2.07M8.51M-2.06M-0.48M-1.85M1.30M1.79M15.11M-3.59M-4.94M-4.50M-2.57M-4.35M10.67M-3.80M
Interest Paid
0.04M0.02M0.01M0.02M0.01M0.01M0.00M0.05M-0.02M0.00M0.01M0.01M0.00M
Income Taxes PaidTaxes Paid

CytoDyn Cash Flow Statement API

Pull CytoDyn's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CYDY&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY